diltiazem has been researched along with Raynaud Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (73.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berk-Krauss, J; Christman, MP; Franks, A; Liebman, TN; Sicco, KL | 1 |
| Pope, J | 1 |
| Capron, L; Fiessinger, JN; Housset, E; Mathieu, JF; Vayssairat, M | 1 |
| Kuwahara, H; Matoba, T; Ogata, M | 1 |
| Seibold, JR; Sturgill, MG | 1 |
| Cremer, MA; Farah, MJ; Massie, JD; Palmieri, GM; Pinals, RS; Sebes, JI | 1 |
| Alpert, MA; Benge, JM; Jackson, RW; Mukerji, V; Pressly, TA; Sharp, GC; Winkler, A | 1 |
| da Costa, J; Espirito Santo, J; Gomes, JA; Queirós, M | 1 |
| Rodeheffer, RJ; Smith, CR | 2 |
| Amor, B; Kahan, A; Menkes, CJ | 1 |
| Ford, PM; McCans, J; Rhedda, A; Willan, AR | 1 |
| Andersson, KE | 1 |
| Russell, IJ; Walsh, RA | 1 |
| Chiba, M; Matoba, T | 1 |
3 review(s) available for diltiazem and Raynaud Disease
| Article | Year |
|---|---|
Raynaud's phenomenon (primary).
Topics: Amlodipine; Diltiazem; Humans; Nafronyl; Nicardipine; Nifedipine; Raynaud Disease; Vasodilator Agents | 2003 |
Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Female; Humans; Male; Nifedipine; Prospective Studies; Random Allocation; Raynaud Disease; Verapamil | 1985 |
Some extracardiac effects of diltiazem and other calcium entry blockers.
Topics: Animals; Asthma; Benzazepines; Calcium Channel Blockers; Diltiazem; Esophageal Diseases; Female; Humans; Hypertension, Pulmonary; Ischemic Attack, Transient; Migraine Disorders; Muscle Contraction; Rats; Raynaud Disease; Urinary Bladder Diseases; Uterine Contraction | 1985 |
5 trial(s) available for diltiazem and Raynaud Disease
| Article | Year |
|---|---|
Diltiazem and Raynaud's syndrome.
Topics: Benzazepines; Clinical Trials as Topic; Diltiazem; Humans; Male; Middle Aged; Raynaud Disease | 1982 |
Inefficacy of diltiazem in the treatment of Raynaud's phenomenon with associated connective tissue disease: a double blind placebo controlled study.
Topics: Collagen Diseases; Diltiazem; Double-Blind Method; Drug Evaluation; Humans; Raynaud Disease | 1987 |
Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Female; Humans; Male; Nifedipine; Prospective Studies; Random Allocation; Raynaud Disease; Verapamil | 1985 |
A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Benzazepines; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Raynaud Disease; Scleroderma, Systemic | 1985 |
A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
Topics: Adolescent; Adult; Aged; Benzazepines; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Female; Humans; Male; Middle Aged; Random Allocation; Raynaud Disease | 1985 |
8 other study(ies) available for diltiazem and Raynaud Disease
| Article | Year |
|---|---|
Botulinum toxin for treatment of Raynaud phenomenon in CREST syndrome.
Topics: Acetylcholine Release Inhibitors; Administration, Topical; Aged; Botulinum Toxins; CREST Syndrome; Diltiazem; Female; Humans; Nitroglycerin; Pain; Raynaud Disease; Sildenafil Citrate; Treatment Failure; Ulcer; Vasodilator Agents | 2018 |
Calcium channel blockers and Raynaud's disease.
Topics: Adult; Benzazepines; Calcium Channel Blockers; Diltiazem; Female; Humans; Ion Channels; Male; Raynaud Disease | 1981 |
Rational use of calcium-channel antagonists in Raynaud's phenomenon.
Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Felodipine; Humans; Isradipine; Nicardipine; Nifedipine; Raynaud Disease | 1998 |
The effect of diltiazem on calcinosis in a patient with the CREST syndrome.
Topics: Administration, Oral; Adult; Bone Density; Calcinosis; Densitometry; Diltiazem; Female; Forearm; Hand; Humans; Radiography; Raynaud Disease | 1990 |
Value and limitations of calcium channel blockade in the treatment of pulmonary hypertension associated with CREST--case reports.
Topics: Adult; Calcinosis; Diltiazem; Esophageal Diseases; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nifedipine; Peristalsis; Raynaud Disease; Scleroderma, Systemic; Syndrome; Telangiectasis | 1988 |
Treatment of Raynaud's phenomenon with calcium channel blockers.
Topics: Calcium Channel Blockers; Diltiazem; Female; Fingers; Humans; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Raynaud Disease; Regional Blood Flow; Toes; Vasoconstriction | 1985 |
Selection of vasodilator therapy for severe Raynaud's phenomenon by sequential arterial infusion.
Topics: Adult; Diltiazem; Female; Humans; Hydralazine; Infusions, Intra-Arterial; Male; Phenoxybenzamine; Plethysmography; Raynaud Disease; Regional Blood Flow; Tolazoline; Vasodilator Agents | 1985 |
Effects of diltiazem on occupational Raynaud's syndrome (vibration disease).
Topics: Benzazepines; Cold Temperature; Diltiazem; Hand; Humans; Male; Middle Aged; Occupational Diseases; Raynaud Disease; Vibration | 1985 |